Skip to content
SentinelMarket desk
Switch to dark mode

쓰리빌리언

394800KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

5,280KRWMarket close of 10/20 (Tue)

Down -1.86%-100KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)5,280KRWFlat 0.00%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
5,320
High
5,370
Low
5,120
Day range
Day range low 5,120 high 5,370, open 5,320, close 5,280, previous close 5,380
Volume
21×10K shares
1.1B KRW 0.22× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 4,060 to 18,800 won, 8% up from the low

8% of the way up from the lowest close in 1 year (252 sessions) · -71.9% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-1.86%usual range
  • Trading value0.2×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters)
  • Revenue3.8B KRWRevenue bars for the last 2 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    +12.8%
  • Operating income-1.7B KRWOperating income bars for the last 2 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    Still a loss
  • Operating margin-43.9%Operating margin bars for the last 2 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    +5.5 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-08-13
2026Q1 -1.7B KRW2026Q2 -1.7B KRW

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.